8-K: Agape ATP Faces Nasdaq Delisting Threat

Agape ATP Corporation received a delisting notice from Nasdaq due to its failure to meet minimum bid price requirements and low-priced stock rules.

Summary

• Agape ATP Corporation (ATPC) received a notification from Nasdaq on January 27, 2026, stating non-compliance with the minimum bid price requirement of $1.00 per share for continued listing.
• An additional notification was received on February 2, 2026, indicating a delisting determination because the common stock had a closing bid price of $0.10 or less for ten consecutive trading days as of January 30, 2026.
• The company intends to request a hearing with the Nasdaq Hearings Panel by February 9, 2026, which will stay the suspension of trading and the filing of Form 25-NSE.
• The fee for the hearing is $20,000.

Sentiment

Score: 1

Explanation: StockSavvy.ai views this as a highly negative development, as a delisting notice from Nasdaq represents a severe blow to investor confidence, liquidity, and the company's market standing.

Positives

• The company intends to request a hearing with the Nasdaq Hearings Panel by February 9, 2026, which will temporarily stay the suspension of trading.

Negatives

• Received a delisting notice from Nasdaq for failing to maintain a minimum bid price of $1.00 per share for 30 consecutive business days.
• Received a subsequent delisting determination for having a closing bid price of $0.10 or less for ten consecutive trading days as of January 30, 2026.
• The company faces a $20,000 fee to request a hearing with the Nasdaq Hearings Panel.

Risks

• Potential delisting of common stock from the Nasdaq Capital Market, which could severely impact liquidity and investor confidence.
• Failure to regain compliance with Nasdaq's minimum bid price and low-priced stock rules.
• The financial cost associated with the delisting appeal process.

Future Outlook

The company intends to request a hearing with the Nasdaq Hearings Panel by February 9, 2026, to appeal the delisting determination. It will continue to evaluate its options and provide updates as appropriate.

Management Comments

• The Company intends to make the request on or prior to February 9, 2026.
• ATPC will continue to evaluate its options and will provide updates as appropriate.

Industry Context

StockSavvy.ai notes that delisting from a major exchange like Nasdaq can severely impact a company's visibility, liquidity, and ability to attract institutional investors. For small-cap companies, maintaining listing compliance is crucial for market access and investor confidence, and failure often signals underlying operational or financial challenges.

Comparison to Industry Standards

• This filing does not provide specific financial or operational results that can be directly compared to industry standards or competitors; the issue is purely regulatory compliance related to stock price.

Stakeholder Impact

• Shareholders face significant risk of reduced liquidity, potential loss of investment value, and difficulty trading shares if delisted to over-the-counter markets.
• Investors may lose confidence in the company's ability to maintain its public listing and attract capital.

Next Steps

• Request a hearing with the Nasdaq Hearings Panel by February 9, 2026.
• Evaluate options regarding the delisting determination.
• Provide updates to the market as appropriate.

Key Dates

Recommendation

The imminent threat of delisting from Nasdaq due to persistent failure to meet minimum bid price requirements and the low-priced stock rule signals severe underlying issues. Delisting would drastically reduce liquidity and investor confidence, making the stock highly speculative and unsuitable for most investors. The $20,000 hearing fee adds to the financial burden without guaranteeing a positive outcome.

Keywords

Nasdaq delisting, minimum bid price, low priced stock, ATPC, Agape ATP Corporation, stock market compliance, securities regulation